GlassScriptPhysician profile
Eric A West
NPI 1255375226
$2,439.29
in general payments reported to CMS, 2019-2025
25 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $48.85 · 2022: $925 · 2023: $428 · 2024: $355 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $621.27 | 2022-2023 | Physio-Stim |
| Pfizer INC. | $325.39 | 2019-2025 | |
| Glaxosmithkline, LLC. | $224.49 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $217.38 | 2023-2025 | Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $180.64 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $171.32 | 2022-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.73 | 2019-2024 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Abbott Laboratories | $113.28 | 2022-2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $98.17 | 2019-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $53.47 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $49.12 | 2024 | Gemtesa |
| Dexcom, INC. | $35.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.76 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $28.30 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $27.71 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.01 | 2024 | Aptima, Thinprep 2000 Processor |
| Phathom Pharmaceuticals, INC. | $16.24 | 2024 | Voquezna |
| Gilead Sciences, INC. | $15.71 | 2025 | |
| Xeris Pharmaceuticals, INC. | $15.41 | 2025 | Gvoke Hypopen |
| Supernus Pharmaceuticals, INC. | $15.00 | 2019 | |
| Organon LLC | $13.77 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.91 | 2023 | Camzyos |
| Amarin Pharma, INC. | $12.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.